Carolina Bigert
Carolina Bigert, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Per Gustavsson
Per Gustavsson, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Kurt Straif
Kurt Straif, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Beate Pesch
Beate Pesch, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Thomas Brüning
Thomas Brüning, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Benjamin Kendzia
Benjamin Kendzia, MSc
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Joachim Schüz
Joachim Schüz, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Isabelle Stücker
Isabelle Stücker, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Florence Guida
Florence Guida, PharmD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Irene Brüske
Irene Brüske, MD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Heinz-Erich Wichmann
Heinz-Erich Wichmann, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Angela C Pesatori
Angela C Pesatori, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Maria Teresa Landi
Maria Teresa Landi, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Neil Caporaso
Neil Caporaso, MD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Lap Ah Tse
Lap Ah Tse, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Ignatius Tak-sun Yu
Ignatius Tak-sun Yu, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Jack Siemiatycki
Jack Siemiatycki, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Javier Pintos
Javier Pintos, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Franco Merletti
Franco Merletti, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Dario Mirabelli
Dario Mirabelli, MD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Lorenzo Simonato
Lorenzo Simonato, MD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Karl-Heinz Jöckel
Karl-Heinz Jöckel, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Wolfgang Ahrens
Wolfgang Ahrens, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Hermann Pohlabeln
Hermann Pohlabeln, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Adonina Tardón
Adonina Tardón, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
David Zaridze
David Zaridze, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
John Field
John Field, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Andrea ‘t Mannetje
Andrea ‘t Mannetje, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Neil Pearce
Neil Pearce, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
John McLaughlin
John McLaughlin, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Paul Demers
Paul Demers, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Neonila Szeszenia-Dabrowska
Neonila Szeszenia-Dabrowska, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Jolanta Lissowska
Jolanta Lissowska, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Peter Rudnai
Peter Rudnai, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Eleonora Fabianova
Eleonora Fabianova, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Rodica Stanescu Dumitru
Rodica Stanescu Dumitru, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Vladimir Bencko
Vladimir Bencko, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Lenka Foretova
Lenka Foretova, MD, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Vladimir Janout
Vladimir Janout, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Paolo Boffetta
Paolo Boffetta, MD, MPH
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Francesco Forastiere
Francesco Forastiere, MD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Bas Bueno-de-Mesquita
Bas Bueno-de-Mesquita, MD, MPH
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Susan Peters
Susan Peters, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Roel Vermeulen
Roel Vermeulen, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Hans Kromhout
Hans Kromhout, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1,
Ann C Olsson
Ann C Olsson, PhD
1Institute of Environmental Medicine (Drs Bigert and Gustavsson), Karolinska Institutet, Stockholm, Sweden; International Agency for Research on Cancer (Drs Straif, Schüz, and Olsson), Lyon, France; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr-Universität Bochum (IPA) (Drs Pesch and Brüning, Mr Kendzia), Germany; Inserm, Centre for Research in Epidemiology and Population Health (CESP) (Drs Stücker and Guida), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France; Université Paris-Sud (Drs Stücker and Guida), UMRS 1018, F-94807, Villejuif, France; Institut für Epidemiologie I (Drs Brüske and Wichmann), Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; Department of Clinical Sciences and Community Health (Dr Pesatori), Università degli Studi di Milano, Milan, Italy; National Cancer Institute (Drs Landi and Caporaso), Bethesda, MD; Division of Occupational and Environmental Health (Drs Tse and Yu), School of Public Health and Primary Care, The Chinese University of Hong Kong, China; Research Centre of University of Montréal Hospital Centre (Drs Siemiatycki and Pintos), University of Montréal, Canada; Cancer Epidemiology Unit (Drs Merletti and Mirabelli), Department of Medical Sciences, University of Turin, Italy; Department of Environmental Medicine and Public Health (Dr Simonato), University of Padua, Italy; Institute for Medical Informatics (Dr Jöckel), Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany; Bremen Institute for Prevention Research and Social Medicine (Drs Ahrens and Pohlabeln), Bremen, Germany; CIBERESP (Dr Tardon), University of Oviedo, Spain; Russian Cancer Research Centre (Dr Zaridze), Moscow, Russia; Roy Castle Lung Cancer Research Programme, Cancer Research Centre (Dr Field), University of Liverpool, UK; Centre for Public Health Research (Drs Mannetje and Pearce), Massey University, Wellington, New Zealand; Occupational Cancer Research Centre (Drs McLaughlin and Demers), Toronto, Canada; The Nofer Institute of Occupational Medicine (Dr Szeszenia-Dabrowska), Lodz, Poland; The M Sklodowska-Curie Cancer Center and Institute of Oncology (Dr Lissowska), Warsaw, Poland; National Institute of Environmental Health (Dr Rudnai), Budapest, Hungary; Regional Authority of Public Health (Dr Fabianova), Banska Bystrica, Slovakia; Institute of Public Health (Dr Dumitru), Bucharest, Romania; Institute of Hygiene and Epidemiology (Dr Bencko), 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Masaryk Memorial Cancer Institute (Dr Foretova), Brno, Czech Republic; Faculty of Medicine (Dr Janout), Palacky University, Olomouc, Czech Republic; The Tisch Cancer Institute and Institute for Translational Epidemiology (Dr Boffetta), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Epidemiology (Dr Forastiere), ASL RomaE, Rome, Italy; The National Institute for Public Health and Environmental Protection (RIVM) (Dr Bueno-de-Mesquita),Bilthoven, the Netherlands; Institute for Risk Assessment Sciences (Drs Peters, Vermeulen, and Kromhout), Utrecht, the Netherlands; Occupational Respiratory Epidemiology (Dr Peters), School of Population Health, University of Western Australia, Perth, Australia
1